Skip to Content


Welcome to the first participants of the GSK TRPV4 Study, June 2018

Professor Lorcan McGarvey, Centre for Experimental Medicine, School of Medicine, Dentistry and Biomedical Sciences at Queen's University Belfast, is conducting a new respiratory research study at the NICRF:

"GSK TRPV4: A placebo-controlled, double-blind (sponsor open), randomised, crossover study to assess the efficacy, safety, and tolerability of GSK2798745 in participants with chronic cough"

Read more about the study here.